603882 金域医学
已收盘 07-16 15:00:00
资讯
新帖
简况
细胞免疫治疗概念盘中跳水,华东医药跌1.06%
市场透视 · 07-15 02:32
细胞免疫治疗概念盘中跳水,华东医药跌1.06%
金域医学股价下跌1.41% 上半年预亏最高9500万元
金融界 · 07-14 19:32
金域医学股价下跌1.41% 上半年预亏最高9500万元
金域医学预计2025年上半年亏损6500万元至9500万元
财中社 · 07-14 11:26
金域医学预计2025年上半年亏损6500万元至9500万元
每周股票复盘:金域医学(603882)股东国创开元拟减持不超过1.00%股份
证券之星 · 07-12
每周股票复盘:金域医学(603882)股东国创开元拟减持不超过1.00%股份
重点研发专项启动!金域医学助力突破神免疾病抗体检测技术瓶颈
金域医学 · 07-10
重点研发专项启动!金域医学助力突破神免疾病抗体检测技术瓶颈
超高性价比的AD惠民早筛服务!金域医学又一新研究发布
金域医学 · 07-09
超高性价比的AD惠民早筛服务!金域医学又一新研究发布
金域医学最新公告:国创开元拟减持不超过1.00%公司股份
证券之星 · 07-08
金域医学最新公告:国创开元拟减持不超过1.00%公司股份
金域医学新注册《金域云检KMC订单管理系统V1.0》等2个项目的软件著作权
证券之星 · 07-07
金域医学新注册《金域云检KMC订单管理系统V1.0》等2个项目的软件著作权
金域医学新注册《金域云检KMC服务工单评价系统V1.0》等2个项目的软件著作权
证券之星 · 07-04
金域医学新注册《金域云检KMC服务工单评价系统V1.0》等2个项目的软件著作权
全员晋级!金域医学3项QC成果拿下全国赛事大奖
金域医学 · 07-04
全员晋级!金域医学3项QC成果拿下全国赛事大奖
每周股票复盘:金域医学(603882)股东质押展期8,580,000股
证券之星 · 06-28
每周股票复盘:金域医学(603882)股东质押展期8,580,000股
体外诊断概念盘中拉升,迪安诊断涨6.02%
市场透视 · 06-27
体外诊断概念盘中拉升,迪安诊断涨6.02%
金域医学早盘冲高涨5.10% 量比激增揭示资金博弈白热化
智选洞察 · 06-27
金域医学早盘冲高涨5.10% 量比激增揭示资金博弈白热化
肝癌甲基化多中心科研启动!金域医学携手河南省中医院共筑健康管理新标杆
金域医学 · 06-26
肝癌甲基化多中心科研启动!金域医学携手河南省中医院共筑健康管理新标杆
基因测序概念盘中拉升,东方海洋涨停
市场透视 · 06-26
基因测序概念盘中拉升,东方海洋涨停
金域医学06月25日主力净流入434.1万元 散户资金抛售
市场透视 · 06-25
金域医学06月25日主力净流入434.1万元 散户资金抛售
金域医学与武汉协和医院达成转化合作,打造VTE精准诊疗“中国方案”
金域医学 · 06-23
金域医学与武汉协和医院达成转化合作,打造VTE精准诊疗“中国方案”
金域医学:圣域钫质押展期858万股
公司公告 · 06-23
金域医学:圣域钫质押展期858万股
广州疾控与金域医学达成战略合作,全面推进“数智疾控”建设
金域医学 · 06-20
广州疾控与金域医学达成战略合作,全面推进“数智疾控”建设
基因测序概念盘中拉升,中元股份涨2.05%
市场透视 · 06-20
基因测序概念盘中拉升,中元股份涨2.05%
加载更多
公司概况
公司名称:
广州金域医学检验集团股份有限公司
所属行业:
卫生
上市日期:
2017-09-08
主营业务:
广州金域医学检验集团股份有限公司的主营业务是第三方医学检验业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司荣获第四届“中国质量奖提名奖”和第十九届“全国质量奖提名奖”,均为业内唯一获得该项国家最高质量荣誉的企业。
发行价格:
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":29.1,"timestamp":1752649201000,"preClose":29,"halted":0,"volume":11405000,"delay":0,"changeRate":0.0034,"floatShares":459999999,"shares":463000000,"eps":-0.8428,"marketStatus":"已收盘","change":0.1,"latestTime":"07-16 15:00:00","open":28.83,"high":29.7,"low":28.73,"amount":332000000,"amplitude":0.0334,"askPrice":29.1,"askSize":268,"bidPrice":29.09,"bidSize":152,"shortable":0,"etf":0,"ttmEps":-0.8428,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752715800000},"marketStatusCode":5,"adr":0,"adjPreClose":29,"symbolType":"stock","openAndCloseTimeList":[[1752629400000,1752636600000],[1752642000000,1752649200000]],"highLimit":31.9,"lowLimit":26.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"isCdr":false,"pbRate":1.96,"roa":"--","roe":"--","epsLYR":-0.82,"committee":-0.285714,"marketValue":13481000000,"turnoverRate":0.0248,"status":0,"floatMarketCap":13390000000},"requestUrl":"/m/hq/s/603882","defaultTab":"news","newsList":[{"id":"2551628130","title":"细胞免疫治疗概念盘中跳水,华东医药跌1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551628130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551628130?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:32","pubTimestamp":1752546776,"startTime":"0","endTime":"0","summary":"07月15日,细胞免疫治疗概念盘中跳水,截至10点32分,细胞免疫治疗概念整体指数下跌2.05%,报938.340点。从个股上来看,该概念的成分股中,华东医药跌1.06%,金域医学、佐力药业、贝达药业跌幅居前。从资金上来看,截止发稿,细胞免疫治疗概念主力净流入为-6.07亿,其中安科生物受到资金热捧,主力净流入6019.62万;拉长时间线来看,该板块近20日主力资金净流入-38.66亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071510325697a66e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071510325697a66e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","LU2328871848.SGD","BK0196","BK0284","BK0188","BK0209","BK0175","BK0183","BK0187","SG9999001069.SGD","LU1969619763.USD","BK0042","BK0132","000963","603882"],"gpt_icon":0},{"id":"2551135801","title":"金域医学股价下跌1.41% 上半年预亏最高9500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135801","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551135801?lang=zh_cn&edition=full","pubTime":"2025-07-15 03:32","pubTimestamp":1752521567,"startTime":"0","endTime":"0","summary":"金域医学7月14日股价收报27.93元,较前一交易日下跌1.41%。盘中最高触及28.43元,最低下探至27.81元,全天成交额1.74亿元。2024年年报显示,其第三方医学诊断业务占比达92.17%。7月14日晚间,金域医学发布业绩预告显示,预计2025年上半年归母净利润亏损6500万元至9500万元,上年同期为盈利8965万元。公司预计计提信用减值损失约2.6亿元至2.9亿元。当日主力资金净流出1199.94万元,占流通市值的0.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071503384597a60b91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071503384597a60b91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","BK0236","BK0042","SG9999001069.SGD","603882"],"gpt_icon":0},{"id":"2551183373","title":"金域医学预计2025年上半年亏损6500万元至9500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551183373","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551183373?lang=zh_cn&edition=full","pubTime":"2025-07-14 19:26","pubTimestamp":1752492363,"startTime":"0","endTime":"0","summary":"7月14日,金域医学(603882)发布公告,公司预计2025年半年度实现归母净利润约亏损6500万元至9500万元,与上年同期的归母净利润8965万元相比,将出现明显亏损。同时,预计扣除非经常性损益后的归母净利润约亏损7800万元至1.1亿元。本期业绩预亏的主要原因包括受经济周期及行业宏观政策环境影响,短期业务发展承压,以及公司为优化客户结构而导致的业务收入不及预期。此外,由于部分应收账款回款周期延长,预计计提信用减值损失约2.6亿元至2.9亿元。2025年一季度,金域医学实现收入14.67亿元,归母净利润-2779万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071419271897a59b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071419271897a59b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","SG9999001069.SGD","BK0042","BK0236","603882"],"gpt_icon":0},{"id":"2551919797","title":"每周股票复盘:金域医学(603882)股东国创开元拟减持不超过1.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2551919797","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551919797?lang=zh_cn&edition=full","pubTime":"2025-07-13 04:32","pubTimestamp":1752352328,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总: 股东国创开元股权投资基金拟减持不超过4632582股,占公司总股本的1.00%公司公告汇总广州金域医学检验集团股份有限公司股东国创开元股权投资基金发布减持股份计划公告。国创开元持有公司30880905股,占公司总股本的6.67%,股份来源于公司首次公开发行前取得的股份。国创开元计划于2025年7月30日至2025年10月29日期间,通过集中竞价方式减持所持有的公司股份不超过4632582股,占公司总股本的1.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300000846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","603882","BK0042","BK0236","SG9999001069.SGD"],"gpt_icon":0},{"id":"2550649076","title":"重点研发专项启动!金域医学助力突破神免疾病抗体检测技术瓶颈","url":"https://stock-news.laohu8.com/highlight/detail?id=2550649076","media":"金域医学","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550649076?lang=zh_cn&edition=full","pubTime":"2025-07-10 18:04","pubTimestamp":1752141896,"startTime":"0","endTime":"0","summary":"金域医学参与河南省重点研发专项该重点专项聚焦神经免疫性疾病自身抗体检测灵敏度低、成本高、耗时长、新型抗体发现滞后等痛点,旨在突破关键技术瓶颈,构建基于细胞载体微流控芯片与人工智能决策的创新诊疗体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710181235a6a1642d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710181235a6a1642d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","SG9999001069.SGD","BK0284","BK0236","BK0042"],"gpt_icon":0},{"id":"2550651589","title":"超高性价比的AD惠民早筛服务!金域医学又一新研究发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2550651589","media":"金域医学","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550651589?lang=zh_cn&edition=full","pubTime":"2025-07-09 18:34","pubTimestamp":1752057284,"startTime":"0","endTime":"0","summary":"作为发病率最高的神经退行性疾病,阿尔茨海默病影响着我国超1000万患者及其家庭。外周血生物标志物检测,因便捷、无创、高效等特点,目前已成为AD早筛的重要方式。更关键的是,该技术与目前临床公认的基于SIMOA的P-tau217检测一致性达88.3%,证实其诊断效能与主流高端技术相当。在保持高精准度的同时,其还具有明显的成本优势,可提供更加经济实惠的AD筛查方案,方便医疗资源有限的地区快速普及AD早筛工作,有效填补基层早筛服务的空白。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709193144a4404642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709193144a4404642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0042","603882","SG9999001069.SGD","BK0236","BK0284"],"gpt_icon":0},{"id":"2549546881","title":"金域医学最新公告:国创开元拟减持不超过1.00%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2549546881","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549546881?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:29","pubTimestamp":1751970584,"startTime":"0","endTime":"0","summary":"金域医学(603882.SH)公告称,公司持股5%以上大股东国创开元计划通过集中竞价方式减持不超过4,632,582股,占公司总股本的1.00%。减持期间为2025年7月30日至10月29日。减持原因是股东自身资金需求。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800032186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882","BK0284","BK0042","BK0236","SG9999001069.SGD"],"gpt_icon":0},{"id":"2549554812","title":"金域医学新注册《金域云检KMC订单管理系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554812","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549554812?lang=zh_cn&edition=full","pubTime":"2025-07-08 01:39","pubTimestamp":1751909953,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学新注册了2个项目的软件著作权,包括《金域云检KMC订单管理系统V1.0》、《金域服务管理kmss知识管理系统V1.0.0》等。今年以来金域医学新注册软件著作权59个,较去年同期增加了436.36%。通过天眼查大数据分析,广州金域医学检验集团股份有限公司共对外投资了58家企业,参与招投标项目28次;财产线索方面有商标信息761条,专利信息205条,著作权信息155条;此外企业还拥有行政许可45个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070800001083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","603882","BK0042","BK0236"],"gpt_icon":0},{"id":"2549934390","title":"金域医学新注册《金域云检KMC服务工单评价系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2549934390","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549934390?lang=zh_cn&edition=full","pubTime":"2025-07-05 01:45","pubTimestamp":1751651116,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金域医学新注册了2个项目的软件著作权,包括《金域云检KMC服务工单评价系统V1.0》、《金域服务管理kmss短信管理系统V1.0.0》等。今年以来金域医学新注册软件著作权57个,较去年同期增加了418.18%。通过天眼查大数据分析,广州金域医学检验集团股份有限公司共对外投资了58家企业,参与招投标项目28次;财产线索方面有商标信息761条,专利信息205条,著作权信息155条;此外企业还拥有行政许可45个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070500001503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0284","BK0236","BK0042","603882"],"gpt_icon":0},{"id":"2548639392","title":"全员晋级!金域医学3项QC成果拿下全国赛事大奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2548639392","media":"金域医学","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548639392?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:59","pubTimestamp":1751623199,"startTime":"0","endTime":"0","summary":"广州金域“重案组”、长沙金域“靶向无敌”QC小组斩获“示范级”成果,济南金域“南波 ONE”QC小组荣获“专业级”成果,全员晋级2026年国际质量管理小组会议推荐赛。本次发布赛历经严格筛选,1280项初审成果中仅571项入选发布。自2019年率先推出“全员创新,全链创新”双创活动,金域医学在质量管理的道路上持续深耕,在国内外权威质量管理活动中屡获佳绩,连续三年拿下ICQCC的最高奖项,树立行业创新标杆。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704190940a436d7f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704190940a436d7f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001069.SGD","BK0236","BK0284","BK0042","603882"],"gpt_icon":0},{"id":"2547706662","title":"每周股票复盘:金域医学(603882)股东质押展期8,580,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2547706662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547706662?lang=zh_cn&edition=full","pubTime":"2025-06-29 03:02","pubTimestamp":1751137336,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘,金域医学报收于28.82元,较上周的26.95元上涨6.94%。本周,金域医学6月27日盘中最高价报29.85元。本次展期质押股份8,580,000股,占圣域钫直接持有公司股份数的40.86%,占公司总股本的1.85%。本次股份质押展期后,公司控股股东、实际控制人梁耀铭及其一致行动人累计质押31,580,000股,占其持有公司股份总数的19.14%,占公司总股本的6.82%。截至公告披露日,梁耀铭及其一致行动人累计质押股份情况详见表格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900000487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","SG9999001069.SGD","BK0042","BK0236","603882"],"gpt_icon":0},{"id":"2546761241","title":"体外诊断概念盘中拉升,迪安诊断涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546761241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546761241?lang=zh_cn&edition=full","pubTime":"2025-06-27 10:21","pubTimestamp":1750990879,"startTime":"0","endTime":"0","summary":"06月27日,体外诊断概念盘中拉升,截至10点21分,体外诊断概念整体指数上涨1.00%,报1071.050点。从个股上来看,该概念的成分股中,迪安诊断涨6.02%,安必平、金域医学2只股涨幅超过5%。从资金上来看,截止发稿,体外诊断概念概念主力净流入为2741.43万,其中乐普医疗受到资金热捧,主力净流入3448.21万;拉长时间线来看,该板块近20日主力资金净流入-31.26亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627102119a71fce1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627102119a71fce1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0186","603882","300244","BK0197","SG9999001069.SGD","688393","BK0114","BK0028","BK0146","BK0284","BK0070","BK0236","BK0042"],"gpt_icon":0},{"id":"2546210761","title":"金域医学早盘冲高涨5.10% 量比激增揭示资金博弈白热化","url":"https://stock-news.laohu8.com/highlight/detail?id=2546210761","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546210761?lang=zh_cn&edition=full","pubTime":"2025-06-27 10:14","pubTimestamp":1750990492,"startTime":"0","endTime":"0","summary":"金域医学早盘股价强势冲高,最新报29.66元/股,涨幅达5.10%,创近几日新高;市场交投活跃,成交额已达1.28亿元,换手率0.96%,振幅为5.32%,呈现放量突破走势。资金博弈与板块轮动共振近期金域医学股价波动受主力资金流向扰动。截至6月26日,近5个交易日主力资金累计净流出837.9万元,但6月25日单日净流入434.1万元,显示机构间存在分歧。技术面上,6月27日早盘量比升至3.73,成交额较前日放大近5倍,显示短期多空博弈进入白热化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627101454a4c01975&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627101454a4c01975&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","SG9999001069.SGD","BK0042","BK0236","603882"],"gpt_icon":0},{"id":"2546778683","title":"肝癌甲基化多中心科研启动!金域医学携手河南省中医院共筑健康管理新标杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2546778683","media":"金域医学","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546778683?lang=zh_cn&edition=full","pubTime":"2025-06-26 17:36","pubTimestamp":1750930609,"startTime":"0","endTime":"0","summary":"为突破这一困境,6月21日,金域医学与河南省中医院联合发起“血浆cfDNA甲基化检测用于体检人群肝癌早期筛查和预警多中心科研项目”,依托前沿分子诊断技术与健康管理经验,探索建立肝癌风险精准预警体系,助力在黄金早诊期发现肝癌。该项目整合金域医学领先的甲基化检测技术平台及河南省中医院在健康管理领域的深厚积淀,通过多中心协作建立肝癌早筛标准化路径,为提升区域肿瘤防治水平提供科研范本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626174458a71ea373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626174458a71ea373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","BK0042","603882","SG9999001069.SGD","BK0284"],"gpt_icon":0},{"id":"2546764142","title":"基因测序概念盘中拉升,东方海洋涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2546764142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546764142?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:49","pubTimestamp":1750902599,"startTime":"0","endTime":"0","summary":"06月26日,基因测序概念盘中拉升,截至09点49分,基因测序概念整体指数上涨0.51%,报1732.190点。从个股上来看,该概念的成分股中,东方海洋涨停,美年健康、迪安诊断、金域医学涨幅居前。从资金上来看,截止发稿,基因测序概念主力净流入为5049.24万,其中东方海洋受到资金热捧,主力净流入1.38亿;拉长时间线来看,该板块近20日主力资金净流入-44.41亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094959a4be4200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094959a4be4200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","SG9999001069.SGD","BK0046","BK0213","002086","603882","BK0042","BK0092","BK0236"],"gpt_icon":0},{"id":"2546047290","title":"金域医学06月25日主力净流入434.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2546047290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546047290?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:20","pubTimestamp":1750836052,"startTime":"0","endTime":"0","summary":"06月25日, 金域医学股价涨1.21%,报收28.44元,成交金额2.1亿元,换手率1.65%,振幅3.35%,量比1.40。金域医学今日主力资金净流入434.1万元,上一交易日主力净流出509.6万元。该股近5个交易日上涨3.46%,主力资金累计净流出1181.4万元;近20日主力资金累计净流出1173.4万元,其中净流出天数为10日。该股主力净额占比0.03%,A股市场排名1540/5420,高于行业平均值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171138a4bd0822&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171138a4bd0822&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","603882","BK0042","BK0236","SG9999001069.SGD"],"gpt_icon":0},{"id":"2545412446","title":"金域医学与武汉协和医院达成转化合作,打造VTE精准诊疗“中国方案”","url":"https://stock-news.laohu8.com/highlight/detail?id=2545412446","media":"金域医学","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545412446?lang=zh_cn&edition=full","pubTime":"2025-06-23 20:36","pubTimestamp":1750682164,"startTime":"0","endTime":"0","summary":"2025年6月22日,金域医学与华中科技大学同济医学院附属协和医院正式签署静脉血栓栓塞症精准诊疗转化合作协议,并启动全国多中心科研项目。双方将聚焦VTE精准诊疗领域,通过产学研协同创新,一方面推动血栓性疾病诊疗技术的临床转化,另一方面构建符合中国人群特征的VTE风险预测模型,为构建中国VTE防治体系注入新动能,打造VTE精准诊疗“中国方案”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623204722a718d6c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623204722a718d6c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0284","SG9999001069.SGD","BK0042","BK0236","603882"],"gpt_icon":0},{"id":"2545418011","title":"金域医学:圣域钫质押展期858万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2545418011","media":"公司公告","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545418011?lang=zh_cn&edition=full","pubTime":"2025-06-23 17:28","pubTimestamp":1750670925,"startTime":"0","endTime":"0","summary":"金域医学公告,公司股东圣域钫办理了858万股的质押展期手续,占其所持股份比例40.86%,占公司总股本1.85%。本次调整后,控股股东及一致行动人累计质押3158万股,占其持股总数的19.14%,占公司总股本的6.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623175427a7187ed0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623175427a7187ed0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0042","603882","BK0236","BK0284","SG9999001069.SGD"],"gpt_icon":0},{"id":"2544281841","title":"广州疾控与金域医学达成战略合作,全面推进“数智疾控”建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2544281841","media":"金域医学","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544281841?lang=zh_cn&edition=full","pubTime":"2025-06-20 17:21","pubTimestamp":1750411312,"startTime":"0","endTime":"0","summary":"2025年6月20日,广州市疾病预防控制中心与金域医学正式签署战略合作协议。双方将以推动疾控工作数字化转型和业务智能化升级为核心,聚焦智慧化多点触发监测预警体系建设、慢性病与地方病风险预警预测等关键领域,依托双方在疾病预防控制领域和医学检验领域的专业沉淀,展开深度协作,全面推进“数智疾控”建设,为广州市疾控高质量发展注入新动能,为地方现代化疾控体系建设提供创新思路。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620173154a7143d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620173154a7143d03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","SG9999001069.SGD","BK0042","BK0236","BK0284"],"gpt_icon":0},{"id":"2544118275","title":"基因测序概念盘中拉升,中元股份涨2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544118275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544118275?lang=zh_cn&edition=full","pubTime":"2025-06-20 09:37","pubTimestamp":1750383460,"startTime":"0","endTime":"0","summary":"06月20日,基因测序概念盘中拉升,截至09点37分,基因测序概念整体指数上涨0.50%,报1685.380点。从个股上来看,该概念的成分股中,中元股份涨2.05%,金域医学、睿昂基因、昌红科技涨幅居前。从资金上来看,截止发稿,基因测序概念主力净流入为-3635.70万,其中贝达药业受到资金热捧,主力净流入382.89万;拉长时间线来看,该板块近20日主力资金净流入-45.95亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506200937409524054d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506200937409524054d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603882","BK0114","BK0028","BK0224","BK0046","688217","300018","BK0146","BK0102","BK0078"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752686323360,"stockEarnings":[{"period":"1week","weight":0.043},{"period":"1month","weight":0.0419},{"period":"3month","weight":0.0164},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.0174},{"period":"ytd","weight":0.0806}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0681},{"period":"6month","weight":0.0808},{"period":"1year","weight":0.1772},{"period":"ytd","weight":0.0454}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"43987人(较上一季度增加20.88%)","perCapita":"10460股","listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","registeredCapital":"46325万元","survey":" 广州金域医学检验集团股份有限公司的主营业务是第三方医学检验业务。公司的主要产品是医学诊断服务、销售诊断产品、健康体检业务、冷链物流服务。公司荣获第四届“中国质量奖提名奖”和第十九届“全国质量奖提名奖”,均为业内唯一获得该项国家最高质量荣誉的企业。","listedPrice":6.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}